A WIMSical approach to decoding DNA methylation in myeloid leukemia.

Genome Biol · 2014 · PMC4397946 · PMID 25315876

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Overall, four small-scale clinical trials that investigated the relationship between DNMT3A mutations and response to hypomethylating agents showed a trend towards prolonged progression-free survival (PFS) and higher complete remission (CR) rate in those carrying the mutation [ 2 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.